The Animal Health Institute today praised Congress for passing the reauthorization of the Animal Drug User Fee Act (ADUFA). ADUFA provides the Food and Drug Administration’s Center for Veterinary Medicine (CVM) with supplemental industry funds in exchange for meeting agreed-upon performance goals. Originally established in 2004, this is the fifth authorization.
AHI thanks the House co-sponsors of this bill, Congressman Greg Pence (R-IN) and Congresswoman Kim Schrier (D-WA), as well as Senate co-sponsors Tammy Baldwin (D-WI) and Markwayne Mullin (R-OK). We also appreciate the work of House and Senate Committee Leaders, Chair Rodgers (R-WA), Ranking Member Pallone (D-NJ), Chairman Sanders (I-VT) and Ranking Member Cassidy (R-LA). Timely reauthorization ensures continuity at CVM and facilitates the approval of needed therapies to meet the many therapeutic needs of our nation’s pets and farm animals.
“This legislation is important to both the animal health industry and CVM,” said AHI President and CEO Alexander S. Mathews. “The products approved by CVM play a critical role not only in protecting animal health but also in safeguarding human health by ensuring our pets are healthy and food from farm animals is safe. Advanced technology promises exciting new innovations for animal health. We look forward to working with CVM to meet the challenge of bringing new products to market to address the many animal diseases and conditions faced by veterinarians and animal owners.”